Another update by Incannex on the NASDAQ tonight.
Potentially a very big market disruptor arriving.
RESMED should take them out soon.
Short Summary Below.
This trial is significant as it follows a successful Phase 2A study that showed a greater than 50% reduction in the apnea hypopnea index (AHI) at low doses, with 25% of patients achieving over 80% reduction.
The trial will span 52 weeks, involving 560 patients across the US, EU, and UK, and aims to provide an alternative to CPAP machines which many patients find intolerable.
www.incannex.com
- Forums
- ASX - By Stock
- Takeover Target Potential?
Another update by Incannex on the NASDAQ tonight.Potentially a...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$27.63 |
Change
-0.110(0.40%) |
Mkt cap ! $17.43B |
Open | High | Low | Value | Volume |
$27.56 | $27.65 | $27.35 | $45.90M | 1.672M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 3206 | $27.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$27.64 | 675 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 3553 | 27.560 |
11 | 4396 | 27.550 |
10 | 1423 | 27.540 |
4 | 1132 | 27.530 |
2 | 2351 | 27.520 |
Price($) | Vol. | No. |
---|---|---|
27.580 | 1253 | 8 |
27.590 | 2703 | 10 |
27.600 | 2779 | 6 |
27.610 | 984 | 2 |
27.630 | 1114 | 2 |
Last trade - 11.02am 25/06/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |